✦ LIBER ✦

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis. Author's reply

✍ Scribed by R. K. Sterling; M. L. Shiffman

Book ID: 108604106
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 36 KB
Volume: 21
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2005.02495.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolate mofetil for the treatment

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

✍ K. B. Lankarani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Tacrolimus for the treatment of primary

Tacrolimus for the treatment of primary sclerosing cholangitis

✍ Jayant A. Talwalkar; Andrea A. Gossard; Jill C. Keach; Roberta A. Jorgensen; Jan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Bezafibrate for the treatment of primary

Bezafibrate for the treatment of primary sclerosing cholangitis

✍ Suguru Mizuno; Kenji Hirano; Minoru Tada; Keisuke Yamamoto; Yoko Yashima; Hirosh 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 168 KB

A prospective, randomized-controlled pil

A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

✍ R. K. Sterling; J. J. Salvatori; V. A. Luketic; A. J. Sanyal; A. S. Fulcher; R. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Pirfenidone in the Treatment of Primary

Pirfenidone in the Treatment of Primary Sclerosing Cholangitis

✍ Paul Angulo; Robert L. MacCarty; Pamela B. Sylvestre; Roberta A. Jorgensen; Russ 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 58 KB

High-dose ursodeoxycholic acid for the t

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

✍ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve